Fairvalue-Calculator Fairvalue-Calculator

Mayr-Melnhof Karton AG (MNHFF) Fair Value & Analysis

Consumer Cyclical · US · Market cap $1.8B

Price$92.59
Fair Value$75.12
Upside-18.9%
Quality95/100
Evidence: High Range $56.34 – $84.41

Analysis

Mayr-Melnhof Karton AG (MNHFF) currently trades at $92.59, while our model-based Fair Value estimate is $75.12 — implying the stock looks roughly 18.9% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Mayr-Melnhof Karton AG, together with its subsidiaries, manufactures and sells carton boards, paper, and folding cartons primarily in Europe. It operates through three segments: MM Food & Premium Packaging, MM Pharma & Healthcare Packaging, and MM Board & Paper. The MM Food & Premium segment processes carton boards into folding cartons primarily for the food industry and other consumer goods industries. The MM Pharma & Healthcare Packaging segment processes carton boards into folding cartons for the pharmaceutical industry, as well as leaflets and labels. The MM Board & Paper segment manufactures and markets carton boards focusing on coated carton board produced from recycled fibres, as well as virgin fibre-based carton boards. It also offers kraft papers, uncoated fine papers, and pulp. The company was founded in 1888 and is based in Vienna, Austria.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.